News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
NABEL ELIZABETH G
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/22/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Accolade, Inc.|
Txns:
| Granted 9,196 restricted stock units
@ $0 |
|
| 07/27/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Accolade, Inc.|
Txns:
| Exercised 14,060 restricted stock units
@ $0 |
|
| 06/01/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Accolade, Inc.|
Txns:
| Exercised 1,752 restricted stock units
@ $0 |
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc|
Txns:
| Granted 1,930 shares
@ $90.68, valued at
$175k
Paid exercise price by delivering 169 shares
@ $90.23, valued at
$15.2k
|
|
| 05/01/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Exercised 670 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Accolade, Inc.|
Txns:
| Granted 7,006 restricted stock units
@ $0 |
|
| 07/27/2022 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Accolade, Inc.|
Txns:
| Granted 14,060 restricted stock units
@ $0 |
|
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Lyell Immunopharma, Inc.|
Txns:
| Granted 65,000 options to buy
@ $5.31, valued at
$345.2k
|
|
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2020 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc|
Txns:
| Paid exercise price by delivering 393 shares
@ $99.14, valued at
$39k
|
|
| 04/30/2020 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Granted 18,270 options to buy
@ $46.37, valued at
$847.2k
|
|
| 04/29/2020 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc|
Txns:
| Granted 1,737 shares
@ $0 |
|
| 06/28/2019 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Granted 54,660 options to buy
@ $14.34, valued at
$783.8k
|
|
| 05/01/2019 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc|
Txns:
| Granted 2,002 shares
@ $0
Paid exercise price by delivering 429 shares
@ $88.81, valued at
$38.1k
|
|
| 12/13/2018 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Converted 13,679 shares
@ $0
Converted 13,679 preferred shares
@ $0 |
|
| 05/02/2018 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc|
Txns:
| Granted 2,184 shares
@ $0
Paid exercise price by delivering 616 shares
@ $81.01, valued at
$49.9k
|
|
| 05/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/04/2016 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc|
Txns:
| Granted 2,206 shares
@ $0 |
|
| 04/29/2016 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc|
Txns:
| Paid exercise price by delivering 166 shares
@ $79.45, valued at
$13.2k
|
|
|
|